[The value of cognitive evoked potentials in assessing the effectiveness of methylphenidate treatment in children with attention deficit hyperactivity disorder]
- PMID: 15736091
[The value of cognitive evoked potentials in assessing the effectiveness of methylphenidate treatment in children with attention deficit hyperactivity disorder]
Abstract
Aim: To investigate the changes of the latency and amplitude of P300 in relation to methylphenidate (MPH) medication.
Subjects and methods: 36 children with attention deficit hyperactivity disorder (ADHD) and 18 children as control group were tested with an auditory and visual oddball paradigm both before and 1.5 h after a single dose trial of MPH.
Results: MPH increased the amplitude and the latency of the visual and auditory P300 component In the ADHD group the latency of the P300 component was longer and the amplitude smaller than in the control group.
Conclusion: These results suggests that MPH acts to improve processing of cognitive information in children with ADHD where no differences with normal children are present.
Similar articles
-
Effect of methylphenidate on auditory event related potential in boys with attention deficit hyperactivity disorder.Int J Pediatr Otorhinolaryngol. 2004 Oct;68(10):1267-72. doi: 10.1016/j.ijporl.2004.04.023. Int J Pediatr Otorhinolaryngol. 2004. PMID: 15364497
-
[Cognitive evoked potentials in the hyperactivity attention deficit disorder].Rev Neurol. 2002 Feb 16-28;34(4):301-5. Rev Neurol. 2002. PMID: 12022041 Spanish.
-
Acute challenge ERP as a prognostic of stimulant therapy outcome in attention-deficit hyperactivity disorder.Biol Psychiatry. 1995 Jan 1;37(1):25-33. doi: 10.1016/0006-3223(94)00075-E. Biol Psychiatry. 1995. PMID: 7893855 Clinical Trial.
-
OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.Expert Rev Neurother. 2009 Aug;9(8):1121-31. doi: 10.1586/ern.09.65. Expert Rev Neurother. 2009. PMID: 19673602 Review.
-
Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.Neurosci Biobehav Rev. 2006;30(8):1225-45. doi: 10.1016/j.neubiorev.2006.10.002. Neurosci Biobehav Rev. 2006. PMID: 17161238 Review.
Cited by
-
Predicting the clinical outcome of stimulant medication in pediatric attention-deficit/hyperactivity disorder: data from quantitative electroencephalography, event-related potentials, and a go/no-go test.Neuropsychiatr Dis Treat. 2014 Feb 3;10:231-42. doi: 10.2147/NDT.S56600. eCollection 2014. Neuropsychiatr Dis Treat. 2014. PMID: 24523588 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous